CelLBxHealth plc
ANPCYOTCHealthcare
$0.07
+$0.00(+0.00%)
Market Cap$21976000
P/E Ratio—
52W High$2.39
52W Low$0.0666
CelLBxHealth plc (ANPCY) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ANPCY · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.86M | $2.19M | $1.04M | $1.01M | $0.76M |
| Cost of Revenue | $1.08M | $2.59M | $0.43M | $0.30M | $0.17M |
| Gross Profit | $1.78M | ($0.41M) | $0.61M | $0.71M | $0.60M |
| Gross Margin %(computed) | 62.16% | -18.66% | 58.89% | 70.19% | 78.35% |
| Operating Expenses | |||||
| R&D Expenses | $1.77M | $9.51M | $10.81M | $8.48M | $7.88M |
| G&A Expenses | $0.46M | $0.38M | $0.56M | $0.34M | $0.37M |
| Total Operating Expenses | $16.88M | $21.35M | $24.82M | $17.95M | $14.33M |
| Operating Income | ($15.10M) | ($21.76M) | ($24.21M) | ($17.23M) | ($13.73M) |
| Operating Margin %(computed) | -527.46% | -995.38% | — | — | — |
| Interest Income | $0.40M | $0.46M | $0.14M | $0.03M | $0.08M |
| Interest Expense | $0.31M | $0.33M | $0.35M | $0.16M | $0.09M |
| Income Before Tax | ($15.03M) | ($21.63M) | ($24.44M) | ($17.36M) | ($13.74M) |
| Income Tax Expense | ($0.80M) | ($1.50M) | ($2.75M) | ($2.35M) | ($2.14M) |
| Net Income | ($14.22M) | ($20.13M) | ($21.69M) | ($15.01M) | ($11.61M) |
| Net Margin %(computed) | -497.03% | -920.95% | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.48 | $-0.77 | $-0.88 | $-0.67 | $-0.65 |
| Wtd Avg Shares | 29.49M | 26.04M | 24.66M | 22.51M | 17.80M |
| EBITDA | ($13.02M) | ($19.00M) | ($24.39M) | ($15.72M) | ($12.23M) |
| EBITDA Margin %(computed) | -455.07% | -869.12% | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · GBP · M
Explore more CelLBxHealth plc data
About CelLBxHealth plc (ANPCY) Income Statement
CelLBxHealth plc (ANPCY) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, ANPCY reported revenue of $0.00B, gross profit of $0.00B (gross margin 62.16%), and net income of ($0.01B) — a net profit margin of -497.03%.
Frequently asked questions
ANPCY · 4 questionsCelLBxHealth plc (ANPCY) reported revenue of $0.00B for 2024, up 30.9% year-over-year.
ANPCY revenueANPCY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09